Blonder Tongue Laboratories EBIT

Blonder Tongue Laboratories posts a EBIT of $-480K as of March 2025. That compares with $-980K in the prior-year period — up 51.1% year over year. That is below the Technology sector average of $80T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Blonder Tongue Laboratories's EBIT was $-980K. The latest reading is $-480K — a 51.1% year-over-year increase (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

For Technology stocks, a EBIT near $80T is typical. Blonder Tongue Laboratories's $-480K is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Blonder Tongue Laboratories's financial statement story. At $-480K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BDRLQ's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $80T), and (3) consistency with growth and profitability. This page covers the first two; Blonder Tongue Laboratories's other metric pages and overview cover the third.